- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06691737
Effect of Whole-body Vibration on Postural Stability, Muscle Flexibility and Lower Limb Power in Young Basketball Players with Generalized Joint Hypermobility
The goal of this clinical trial is to assess the effect of whole body vibration (WBV) on postural stability, flexibility of the lumbar-pelvic-hip complex and lower leg muscles, and jumping ability in basketball players aged 9-15 years. The main questions it aims to answer are:
Does WBV affect the level of postural stability in basketball players aged 9-15 years? Does WBV affect the level of postural stability in basketball players aged 9-15 years? Does WBV affect the flexibility of the iliopsoas, rectus femoris, posterior group of hamstrings, soleus and gastrocnemius in basketball players aged 9-15 years? Does WBV affect the jump height, relative peak power, contraction time in basketball players aged 9-15 years?
Participants will take part in 6 vibration sessions at 20Hz over 6 weeks. Vibration will be performed on the Galileo Med35 platform (3x3 min).
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Formella, Master
- Phone Number: +48 789 251 377
- Email: formella-oskar@wp.pl
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Men aged 9-15
- Playing basketball in a sports club at least 2 training sessions a week
Exclusion Criteria:
- Thrombosis (acute narrowing of blood vessels),
- Inflammation of the musculoskeletal system,
- Arthropathy,
- Hernias,
- Discopathies,
- Tendonitis,
- Fresh fractures,
- Scars,
- Surgeries,
- Kidney stones,
- Rheumatoid arthritis,
- Implants in the body,
- Epilepsy,
- Current injuries to the musculoskeletal system,
- Occurrence of chronic pain complaints of the musculoskeletal system.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Generalized Joint Hypermobility
|
Whole body vibration consists of 3-minute vibrations with a 30-second break.
Participants were asked to step onto the platform barefoot and position their feet "3" from the center of the platform, with feet pointing forward, knees slightly bent, and upper limbs along the body.
The training was divided into two parts: week 1 with a frequency of 20 Hz, and a constant amplitude of 3 mm.
|
|
Experimental: Not Generalized Joint Hypermobility
|
Whole body vibration consists of 3-minute vibrations with a 30-second break.
Participants were asked to step onto the platform barefoot and position their feet "3" from the center of the platform, with feet pointing forward, knees slightly bent, and upper limbs along the body.
The training was divided into two parts: week 1 with a frequency of 20 Hz, and a constant amplitude of 3 mm.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in Postural Stability
Time Frame: 6 weeks before the intervention, the day before the intervention began, the day after the intervention, and 6 weeks after the intervention.
|
Postural stability was measured as the overall stability index (OSI) on the Biodex Balance System on the stable and unstable platform with open and closed eyes.
|
6 weeks before the intervention, the day before the intervention began, the day after the intervention, and 6 weeks after the intervention.
|
|
Range of motion (ROM) of the ankle, knee, and hip joints.
Time Frame: 6 weeks before the intervention, the day before the intervention began, the day after the intervention, and 6 weeks after the intervention.
|
Range of motion (ROM) of the ankle, knee, and hip joints, will be measured in a resting position using an inclinometer for the iliopsoas, rectus femoris, posterior hamstring, soleus, and gastrocnemius muscles separately.
|
6 weeks before the intervention, the day before the intervention began, the day after the intervention, and 6 weeks after the intervention.
|
|
Countermovement Jump Performance
Time Frame: 6 weeks before the intervention, the day before the intervention began, the day after the intervention, and 6 weeks after the intervention.
|
Countermovement jump performance will be measured by using force plates, It will be assessed Jump height (JH), relative peak power (RPP), and contraction time (CT).
|
6 weeks before the intervention, the day before the intervention began, the day after the intervention, and 6 weeks after the intervention.
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AWFiS/2024_4_OF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Generalized Joint Hypermobility
-
Gazi UniversityCompletedGeneralized Joint HypermobilityTurkey
-
Beylikduzu State HospitalNot yet recruiting
-
Istanbul Physical Medicine Rehabilitation Training...CompletedUltrasonography | Hypermobility Syndrome (Disorder) | Median NerveTurkey (Türkiye)
-
Nigde Omer Halisdemir UniversityCompletedSleep | Infant | Joint Hypermobility SyndromeTurkey (Türkiye)
-
University of Southern DenmarkOdense Patient Data Explorative Network; Independent Research Fund DenmarkRecruitingKnee Discomfort | Hypermobility, Joint | Hypermobility SyndromeDenmark
-
Ehab A. AbdallahHorus UniversityNot yet recruitingGrip Strength | Hand Joint HypermobilityEgypt
-
Beylikduzu State HospitalNot yet recruitingHypermobility, JointTurkey
-
Biruni UniversityCompletedHypermobility, JointTurkey
-
Kutahya Health Sciences UniversityCompleted
-
Kutahya Health Sciences UniversityCompleted
Clinical Trials on Whole Body Vibration
-
The Hong Kong Polytechnic UniversityCompleted
-
Pamukkale UniversityNot yet recruitingPatellofemoral Pain, PFPTurkey (Türkiye)
-
Gazi UniversityGulhane Training and Research HospitalCompletedArthropathy of Knee | Whole-body Vibration | Swelling/ EdemaTurkey
-
The Hong Kong Polytechnic UniversityUnknown
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityCompletedHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Chemotherapy-Induced Peripheral NeuropathyUnited States
-
University of the Balearic IslandsUnknown
-
Cairo UniversityRecruitingOverweight , ObesitySaudi Arabia
-
Cairo UniversityCompletedObesity | OverweightSaudi Arabia
-
Cairo UniversityNot yet recruitingQuality of Life | Balance | Chemotherapy Induced Peripheral Neuropathy (CIPN) | Fall Risk, Fall Prevention | Whole Body Vibration